Evidence has revealed that high expression of PD-L1 is correlated with advanced histology and lymph node metastasis in TNBC and HER2+ subtypes, indicating a poor prognosis biomarker [39]. Here, CD274 is linked to metastatic malignant neoplasm in the lymph nodes.